Features & Articles
Filter By
Understanding antibodies in COVID-19
Ghady Haidar is learning more about vaccination efficacy in immunocompromised patients and beyond.
Mentorship starts student on the right foot
Rising senior Dalya Berkowitz credits her mentor, Pitt political scientist Burcu Savun, with the support and research experience needed to give her career in international relations a running start.
A Silver Bullet?
They’re on your toothbrush, in your clothes and mixed into your makeup: Silver nanoparticles have germ-killing properties, but could they be adding to antimicrobial resistance?
20 Projects Receive Pitt Seed Funding
The Pitt Seed Grant program, now in its fourth year, will provide funding to projects from 16 units, schools and divisions across the University and support the goals of Pitt’s strategic plan.
More Americans Are Receiving Addiction Treatment, But Gaps Persist
The largest-ever analysis of opioid use disorder among Medicaid recipients, led by Pitt Public Health Professor Julie Donohue, gives key insights on improving access to quality treatment.
New Partnership to Accelerate Therapies for Genetic Diseases and Cancers
Pitt will collaborate with BridgeBio Pharma, Inc. to identify and support the development of novel therapies for patients with genetic diseases and cancers with clear genetic drivers.
Research updates: Making progress on an ‘antibiotic nightmare’
In 2019, Graham Hatfull’s research on bacteria-killing viruses saved a British teenager’s life. A new patient’s case further advances the science behind curing antibiotic-resistant lung infections.
Waves of COVID-19 washed across North America
COVID-19 surges don’t care about borders or politics — instead they look more like weather patterns, flowing across the North American continent.
Predicting pelvic health
Childbirth is a momentous time. It’s also one of the most significant biomechanical events in life. Steven Abramowitch is using computer models to learn more about the pelvis after delivery.
Enrollment Begins for COVID-19 Pediatric Vaccine Trial
The Pittsburgh Vaccine Trials Unit has joined the KidCOVE Moderna vaccine trial to determine the shot’s efficacy in children. Find out how you can volunteer.
COVID-19 and Lingering Neurological Problems
A global study led by Pitt’s Sherry Chou found that eight out of 10 adults hospitalized with COVID-19 develop neurological problems, and they are six times more likely to die.
Leeches Get a Bad Rap
Leeches are all too happy to latch onto reattached body parts, skin grafts and transplanted tissue. Pitt Med magazine explains medicinal parasites in kid-friendly language.
Pitt leads formation of Pittsburgh Life Sciences Alliance
Launched with a $1.2 million grant from the Richard King Mellon Foundation, the nonprofit, membership-based organization will help the region become a hub for the emerging life sciences economy.
Pitt Disinformation Lab launches
“It’s not just the federal government and social media platforms that have a role to play in combating disinformation,” says Pitt Cyber founding director David Hickton of the new Pitt Disinformation
Unhindered
In January 2019, Pitt people performed UPMC’s first-ever in utero surgery for spina bifida. See how toddler Emery Greene Mullen is doing today.
Printing a better microgrid
Future electronic displays will be thin, flexible and durable. Pitt engineers are finding ways to make the tech better and cheaper through tiny electric grids.
New views on sickle cell
Learn about the new imaging techniques Pitt bioengineering researchers are using to study the disease’s impact on the brain.
Book excerpt: a massacre, not a riot
Ahead of the centennial of the Tulsa Race Massacre on May 31, read an excerpt from Professor Alaina E. Roberts’ new book that depicts the lead-up to and aftermath of that brutal event.
A Curie-ous connection to Pitt
A century ago, Pitt played host to the world’s foremost female scientist, Marie Curie. But Pitt’s connections to the two-time Nobel Prize winner’s work go far beyond the honorary doctoral degree she
Inhaled Nanobodies Effective Against COVID-19 in Hamsters
Promising early data suggest that this approach can provide a convenient and cost-effective therapeutic option to control the coronavirus pandemic.
